Understanding COVID-19 spread and prevention among migrant workers in Greece
Covid-19 transmission, testing, and vaccination dynamics within migrant worker social networks
This study looks at how COVID-19 spreads among migrant workers in Greece and what helps or hinders their access to testing, treatment, and vaccines, with the goal of finding better ways to keep them and their communities healthy.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11049141 on NIH RePORTER |
What this research studies
This research investigates how COVID-19 spreads within the social networks of migrant workers in Greece, focusing on their access to testing, treatment, and vaccination. By analyzing these networks, the study aims to identify barriers and facilitators to effective COVID-19 prevention among this vulnerable population. The research employs social network analysis to uncover the dynamics of transmission and to develop strategies that can improve health outcomes for migrant workers and their communities. The findings could inform public health initiatives aimed at enhancing pandemic preparedness and response.
Who could benefit from this research
Good fit: Ideal candidates for this research include migrant workers in Greece who are at risk of COVID-19 and have limited access to healthcare resources.
Not a fit: Patients who are not part of the migrant worker population or those living outside of Greece may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved COVID-19 prevention strategies that protect migrant workers and their communities from future outbreaks.
How similar studies have performed: Previous research has shown success in using social network analysis to understand disease transmission dynamics, indicating that this approach is promising for addressing COVID-19 among migrant populations.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Schneider, John — University of Chicago
- Study coordinator: Schneider, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.